Scandalous: HSE refuses to pay for life-saving drug for Cystic Fibrosis patients
The HSE has once again revealed its inhuman face, after deciding not to fund a life-saving drug for Cystic Fibrosis (CF) sufferers. The drug in question, Ivacaftor/Lumacaftor (commercial name Orkambi), was developed by American pharma …
